Hasil Pencarian - S A Shevaani

  • Menampilkan 1 - 2 hasil dari 2
Perbaiki Hasil
  1. 1
    Siltuximab - A monoclonal antibody against the interleukin-6 receptor is not an ideal option for management of COVID-19

    Siltuximab - A monoclonal antibody against the interleukin-6 receptor is not an ideal option for management of COVID-19 oleh I Jerlin Michelle, S A Shevaani, Kiran Kumar Rathinam, Justin Jacob Abraham, Muhasaparur Ganesan Rajanandh, Thangavel Mahalingam Vijayakumar

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Tolerability of Sarilumab – An anti-interleukin-6 receptor monoclonal antibody is controversial for the management of COVID-19

    Tolerability of Sarilumab – An anti-interleukin-6 receptor monoclonal antibody is controversial for the management of COVID-19 oleh Justin Jacob Abraham, I Jerlin Michelle, S A Shevaani, Kiran Kumar Rathinam, Muhasaparur Ganesan Rajanandh, Vijayakumar Thangavel Mahalingam

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: